EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)

$8.11 0.04 (0.4957%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 65

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) News Sources

Eupraxia Pharmaceuticals Reports First Quarter 2026 Financial Results

12-05-2026

yahoo.com

Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

28-05-2026

yahoo.com

Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders

19-06-2026

yahoo.com

Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization

07-07-2026

yahoo.com

Eupraxia Pharmaceuticals Strengthens Executive Leadership Team to Support Next Phase of Growth

13-07-2026

yahoo.com

Wall Street Analysts See a 145.35% Upside in Eupraxia Pharmaceuticals Inc. (EPRX): Can the Stock Really Move This High?

10-08-2026

yahoo.com

Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results

11-08-2026

yahoo.com

Eupraxia Pharmaceuticals Reports Symptom Response Data from its Ongoing Phase 1b/2a RESOLVE Trial, Including New Data on Odynophagia (Painful Swallowing) in Eosinophilic Esophagitis Patients

13-08-2026

yahoo.com

Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences

08-09-2026

yahoo.com

Eupraxia Pharma (EPRX): When Painful Swallowing Nearly Disappeared, Investors Took Notice

12-09-2026

yahoo.com

EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) Sentiment Trend

0 25 50 75 100 88 85 65 80 82 34 84 8 66 59 12-05-2026 28-05-2026 19-06-2026 07-07-2026 13-07-2026 10-08-2026 11-08-2026 13-08-2026 08-09-2026 12-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) FAQs

toggle

What is the current price of EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)?

The current price of EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) is $8.11.


toggle

EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) absolute price change since previous trading day?

The absolute price change of EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) since the previous trading day is $0.04.


toggle

EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) percentage price change since previous trading day?

The percentage price change of EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) since the previous trading day is 0.4957%.


toggle

What is the most recent average sentiment score for EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)?

The most recent average sentiment score for EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) is 65 out of 100.


toggle

What is the most recent average sentiment for EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)?

The most recent sentiment for EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ) is .


SEC-8K** Filing Available For EUPRAXIA PHARMACEUTICALS INC (EPRX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.